📣 VC round data is live. Check it out!

Doximity Valuation Multiples

Discover revenue and EBITDA valuation multiples for Doximity and similar public comparables like SoundHound, Lumine Group, Waystar, Box and more.

Doximity Overview

About Doximity

Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.


Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Doximity Financials

Doximity reported last 12-month revenue of $649M and EBITDA of $353M.

In the same LTM period, Doximity generated $585M in gross profit, $353M in EBITDA, and $298M in net income.

Revenue (LTM)


Doximity P&L

In the most recent fiscal year, Doximity reported revenue of $645M and EBITDA of $358M.

Doximity is profitable as of last fiscal year, with gross margin of 89%, EBITDA margin of 55%, and net margin of 47%.

See analyst estimates for Doximity
LTMLast FY202320242025202620272028
Revenue$649M$645M$461M$547M$626M
Gross Profit$585M$575M$410M$492M$560M
Gross Margin90%89%89%90%89%
EBITDA$353M$358M$170M$226M$232M
EBITDA Margin54%55%37%41%37%
EBIT Margin53%54%35%39%35%
Net Profit$298M$303M$139M$204M$203M
Net Margin46%47%30%37%32%

Financial data powered by Morningstar, Inc.

Doximity Stock Performance

Doximity has current market cap of $4B, and enterprise value of $3B.

Market Cap Evolution


Doximity's stock price is $21.40.

Doximity share price decreased by 12.4% in the last 30 days, and by 58.9% in the last year.

Doximity has an EPS (earnings per share) of $1.66.

See more trading valuation data for Doximity
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$4B0.0%-12.4%-12.8%-58.9%$1.66

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Doximity Valuation Multiples

Doximity trades at 4.9x EV/Revenue multiple, and 9.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Doximity

EV / Revenue (LTM)


Doximity Financial Valuation Multiples

As of June 1, 2026, Doximity has market cap of $4B and EV of $3B.

Doximity has a P/E ratio of 13.1x.

LTMLast FY202320242025202620272028
EV/Revenue4.9x4.9x6.9x5.8x5.1x
EV/EBITDA9.0x8.9x18.6x14.0x13.7x
EV/EBIT9.2x9.1x19.8x14.7x14.5x
EV/Gross Profit5.4x5.5x7.7x6.5x5.7x
P/E13.1x12.9x28.2x19.2x19.3x
EV/FCF10.2x10.0x17.9x13.0x10.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Doximity Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Doximity Margins & Growth Rates

Doximity grew revenue by 4% but EBITDA decreased by 8% in the last fiscal year.

In the most recent fiscal year, Doximity reported gross margin of 89%, EBITDA margin of 55%, and net margin of 47%.

See estimated margins and future growth rates for Doximity

Doximity Margins

Last FY202420252026202720282029
Gross Margin89%90%89%88%
EBITDA Margin55%41%37%46%
EBIT Margin54%39%35%44%
Net Margin47%37%32%39%
FCF Margin49%45%49%45%

Doximity Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%18%15%6%
Gross Profit Growth3%20%14%5%
EBITDA Growth(8%)33%3%31%
EBIT Growth(8%)35%1%35%
Net Profit Growth(8%)47%(1%)27%
FCF Growth(9%)38%25%(3%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Doximity Operational KPIs

Doximity's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.4M for the same period.

Doximity's Rule of 40 is 52% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Doximity's Rule of X is 61% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Doximity
LTMLast FY202320242025202620272028
Rule of 4059%52%---
Bessemer Rule of X65%61%---
Revenue per Employee-$0.8M---
Opex per Employee-$0.4M---
S&M Expenses to Revenue19%25%28%26%25%
G&A Expenses to Revenue5%10%8%8%10%
R&D Expenses to Revenue13%20%18%17%19%
Opex to Revenue-56%54%51%54%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
SoundHound21.8x18.9x129.5x(63.8x)
Lumine Group5.4x4.9x14.5x13.7x
Waystar4.7x4.4x11.1x10.4x
Box3.6x3.5x11.8x11.5x
ACADIA Pharmaceuticals2.7x2.5x24.9x30.9x
Kakaku.com7.8x6.2x18.4x19.2x
RingCentral1.9x1.9x7.3x7.0x
Monday.com2.6x2.4x19.5x17.8x

This data is available for Pro users. Sign up to see all Doximity competitors and their valuation data.

Start Free Trial

Doximity Funding History

Before going public, Doximity raised $54M in total equity funding, across 1 round.


Doximity Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Apr-14Series CCanvas Prime; Emergence Capital; InterWest Partners; Morgan Stanley; T. Rowe Price$54M-Doximity is a secure online network for U.S. physicians and advanced practice clinicians, founded in 2011, connecting over 70% of all U.S. doctors by 2014 for collaboration, career management, and productivity tools. The platform offers features tailored to clinicians' needs, such as secure communication and tools exceeding engagement of general professional networks despite doctors' time constraints. Partners include 14 of the 20 largest hospitals like Johns Hopkins and Mount Sinai. The funding supported growth, with nine out of ten fourth-year medical students joining, signaling strong future prospects. Doximity's subscription model drives revenue from pharmaceutical manufacturers and health systems via land-and-expand strategies, achieving 153% net revenue retention as of March 31, 2021.

Doximity M&A Activity

Doximity has acquired 4 companies to date.

Last acquisition by Doximity was on August 7th 2025. Doximity acquired Pathway Medical for $26M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Doximity

Pathway Medical
Amion
THMED
Curative
Description
Pathway Medical is a San Francisco-headquartered health tech firm building an AI-driven medical knowledge graph aggregating data from 30 million publications and clinical guidelines. Its platform delivers evidence-based decision support to physicians via mobile apps during consults, covering cardiology, oncology, and neurology. Used by 500 U.S. hospitals, Pathway integrates with Epic and Cerner EHRs, reducing diagnostic errors by 25% in pilot studies since 2020.
Amion is a Boston-based software provider of web and mobile scheduling tools for healthcare groups including hospitals and physician practices. Operational since 1999, it enables equitable rotation building, shift swaps, and request submissions synced to Google Calendar and Outlook. Over 1,000 organizations use Amion for 24/7 coverage in specialties like surgery, radiology, and emergency medicine. The platform delivers secure messaging, time-off tracking, and payroll exports, with HIPAA-compliant access across iOS, Android, and desktops.
THMED is a healthcare staffing agency headquartered in Franklin, Tennessee, providing permanent placement for nurses, therapists, and allied health professionals. The firm recruits for hospitals, clinics, and long-term care facilities across the United States, filling roles in emergency, surgical, and rehabilitation departments. THMED sources candidates from national databases and offers compliance verification with Joint Commission standards. Established in 2015, it maintains contracts with over 150 healthcare providers in the Southeast and Midwest regions.
Curative is a healthcare staffing firm specializing in locum tenens and permanent placements for physicians, nurses, and allied health professionals. Powered by Doximity's medical network, the company matches candidates using data-driven algorithms across specialties like emergency medicine and anesthesiology. Curative serves hospitals and clinics nationwide from its headquarters in Englewood, Colorado. The firm expanded through acquisition of THMED in 2021, enhancing its travel nursing division and permanent recruitment services.
HQ CountryCanadaUnited StatesUnited StatesUnited States
HQ City
Montreal
Boston, MA
Dallas, TX
Dallas, TX
Deal Date7 Aug 20258 Feb 202217 Jun 202016 Jun 2020
Valuation$26M$54Mundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Doximity acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Doximity

When was Doximity founded?Doximity was founded in 2010.
Where is Doximity headquartered?Doximity is headquartered in United States.
How many employees does Doximity have?As of today, Doximity has over 830 employees.
Who is the CEO of Doximity?Doximity's CEO is Jeffrey Tangney.
Is Doximity publicly listed?Yes, Doximity is a public company listed on NYSE.
What is the stock symbol of Doximity?Doximity trades under DOCS ticker.
When did Doximity go public?Doximity went public in 2021.
Who are competitors of Doximity?Doximity main competitors include SoundHound, Lumine Group, Waystar, Box, ACADIA Pharmaceuticals, Kakaku.com, RingCentral, Monday.com, Life360, JOYY.
What is the current market cap of Doximity?Doximity's current market cap is $4B.
What is the current revenue of Doximity?Doximity's last 12 months revenue is $649M.
What is the current revenue growth of Doximity?Doximity revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Doximity?Current revenue multiple of Doximity is 4.9x.
What is the current EBITDA of Doximity?Doximity's last 12 months EBITDA is $353M.
What is Doximity's EBITDA margin?Doximity's last 12 months EBITDA margin is 54%.
What is the current EV/EBITDA multiple of Doximity?Current EBITDA multiple of Doximity is 9.0x.
What is the current FCF of Doximity?Doximity's last 12 months FCF is $310M.
What is Doximity's FCF margin?Doximity's last 12 months FCF margin is 48%.
What is the current EV/FCF multiple of Doximity?Current FCF multiple of Doximity is 10.2x.
How many companies Doximity has acquired to date?As of June 2026, Doximity has acquired 4 companies.
What was the largest acquisition by Doximity?$54M acquisition of Amion on 8th February 2022 was the largest M&A Doximity has done to date.
What companies Doximity acquired?Doximity acquired Amion, Pathway Medical, Curative, and THMED.
In how many companies Doximity has invested to date?Doximity hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Doximity

Lists including Doximity

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial